Comparing Outpatient and Inpatient Use of a Cervical Balloon for Starting Labor in Low-Risk Pregnancies.
NCT ID: NCT06983535
Last Updated: 2025-05-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
358 participants
INTERVENTIONAL
2016-08-15
2024-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
What was the aim of the study? The researchers wanted to compare how safe and effective this balloon method is when used at home (outpatient) versus in the hospital (inpatient). They also wanted to know how satisfied women were with each approach.
How was the study done? The study took place at four hospitals in Belgium between 2017 and 2023. It included women with healthy low risk pregnancies who were scheduled for induction for non-urgent reasons, such as being past their due date, having a large baby, or by personal choice after 38 weeks of pregnancy.
The women were randomly placed into two groups:
Outpatient setting: going home after balloon placement.
Inpatient setting: staying in the hospital after balloon placement\<
The main thing researchers measured was whether the baby's heart rate pattern (checked by CTG monitoring) was abnormal after 12 hours. They also looked at how the baby was born (vaginal birth or C-section), how long labor took, whether additional medicine was needed, pain management, and how satisfied the mothers were with the process.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Induction to Labour With Double Cervical Ballon at Home Versus at Hospital
NCT06053073
Comparison Between Two Medical Devices for Labor Induction After Previous C-section
NCT06506721
Cook Balloon Versus Propess After 12 Hours of Rupture of Membranes
NCT03310333
Comparison of Pre-Induction Cervical Ripening
NCT01390233
Balloon Catheter Versus Propess for Labour Induction
NCT03199820
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This was a randomised controlled trial - a scientific study designed to compare two groups as fairly as possible. It took place in four hospitals in Belgium:
Ziekenhuis Oost-Limburg (ZOL), Genk
AZ Sint-Lucas, Brugge
Jessa Ziekenhuis, Hasselt
University Hospital Antwerp (UZA), Antwerp
The study ran from May 2017 to November 2023. It was carefully reviewed and approved by the Ethics Committee of ZOL Genk and the review boards of the other hospitals to make sure it followed strict ethical and safety standards.
Who Could Take Part?
Women were eligible to join the study if they:
Were over 18 years old
Were pregnant with just one baby
Had a baby in the head-down (cephalic) position
Had a Bishop Score of 6 or less (indicating the cervix wasn't ready for labor)
Needed their labor to be induced for low-risk reasons, such as:
Being past their due date (post-term)
Suspected large baby (macrosomia)
Personal request to induce labor after 38 weeks of pregnancy
Women were not allowed to join the study if they had any of the following:
Twins or more (multiple pregnancy)
Preterm premature rupture of membranes (water breaking too early)
A baby not growing well (fetal growth restriction)
A condition called placenta accreta spectrum (PAS)
A previous cesarean section
Baby not in head-down position
Gestational diabetes or high blood pressure during pregnancy
Lived more than 60 minutes away from the hospital
Any other health issues (maternal or fetal) or reason that made vaginal birth unsafe
How Were Women Assigned to Groups? Women were told about the study by their doctor in the days leading up to labor induction. On the day of induction, a hospital doctor checked if they met the criteria. If they did, the woman was asked to sign a consent form to take part in the study.
Once enrolled, each woman was randomly assigned to one of two groups:
Inpatient group - stayed in the hospital after balloon insertion
Outpatient group - went home after balloon insertion
The randomisation was done using a computer program, so neither the doctors nor patients could influence which group they were placed into. Because it was obvious who went home and who stayed, this study was not blinded.
The Induction Procedure All four hospitals had experience using mechanical methods to start labor. Before the study began, all staff received a brief training guide to ensure the procedure was done the same way in every hospital.
How the Balloon Was Inserted:
A double-balloon catheter (Cook balloon) was gently inserted into the cervix using a special tool under direct view with a vaginal speculum.
The lower balloon (inside the uterus) was first filled with 20 ml of saline.
The balloon was pulled back so that it rested properly in the cervix.
Then both balloons (one inside the uterus and one in the vagina) were gradually filled with saline up to 80 ml each.
The catheter was taped to the woman's thigh to keep it in place, but no tension or pulling was applied.
After insertion, each woman was monitored for 2 hours using CTG to check the baby's heart rate and any contractions.
If the CTG after balloon insertion was not normal (e.g., slow heartbeat, signs of stress), the woman stayed in the hospital, even if she was in the outpatient group.
Outpatient Group: Going Home If the CTG was normal, women in the outpatient group went home with the balloon still in place and were asked to return to the hospital 12 hours later, unless one of the following happened: their water broke (spontaneous rupture of membranes), they started having strong or painful contractions, the balloon came out or moved, they experienced non-tolerable pain or felt anxious, they simply didn't want to go home.
Before going home, every woman was given clear, written instructions about: when to come back early, what warning signs to look for, how to call the hospital, they also received a follow-up call from the doctor on duty 1-2 hours after leaving, to check how they were doing.
After 12 Hours: Balloon Removal and Next Steps. Twelve hours after the balloon was placed (or sooner, if needed), the balloon was removed. At that time the Bishop Score was checked again to see if the cervix had softened or opened. A new CTG was performed to make sure the baby was doing well.
What happened next depended on how the cervix looked: if the cervix was still not ready (Bishop Score ≤ 6):
→ Labor was continued using prostaglandins (a medication to soften the cervix)
If the cervix was ready (Bishop Score \> 6) and effaced (thinned out):
→ Labor was started by breaking the water (amniotomy) and giving oxytocin to strengthen contractions
If the cervix was open but not thinned, doctors often chose oral or vaginal prostaglandins instead of breaking the water.
All clinical details were recorded by trained hospital staff.
Primary Outcome (Main Focus):
The baby's wellbeing as seen on the CTG (heart rate monitor) right after the balloon was inserted and again when it was removed (or sooner if problems occurred).
Secondary Outcomes (Other Important Measures):
1. Maternal Clinical Outcomes:
How the baby was delivered (normal, assisted with vacuum or forceps, cesarean)
Pain relief used (e.g., paracetamol, pethidine, epidural)
Use of labor medications like oxytocin
2. Process Outcomes:
How long the entire induction process took:
From hospital admission to discharge
From balloon placement to delivery
From balloon removal to delivery
3. Maternal Satisfaction:
Assessed using a detailed 16-question survey sent by email 1-2 days after delivery
Topics included overall experience, comfort, timing, and whether they'd choose the same method again
4. Maternal Health Concerns:
Possible complications like:
Uterine hyperstimulation (too many contractions)
Placental abruption (placenta detaching early)
Infections needing antibiotics
Doctors also recorded why some women needed C-sections or assisted births.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Inpatient
Patient in this arm were randomized to stay in the hospital during cervical balloon ripening
cervical balloon catheter
Patients will be randomized to inpatient or outpatient setting while having the cervical ripening balloon catheter
Outpatient
Patients in this arm were randomized to ambulant home setting during cervical ripening
cervical balloon catheter
Patients will be randomized to inpatient or outpatient setting while having the cervical ripening balloon catheter
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cervical balloon catheter
Patients will be randomized to inpatient or outpatient setting while having the cervical ripening balloon catheter
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AZ Sint-Lucas Brugge
OTHER
University Hospital, Antwerp
OTHER
Jessa Hospital
OTHER
Ziekenhuis Oost-Limburg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zoe Pieters
Role: STUDY_CHAIR
Data Science Institute, Hasselt University, Diepenbeek, Belgium.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospitals Antwerp
Antwerp, Antwerp, Belgium
Ziekenhuis Oost-Limburg
Genk, Limburg, Belgium
Jessa Ziekenhuis
Hasselt, Limburg, Belgium
AZ Sint Lucas
Bruges, West-Vlaanderen, Belgium
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Alfirevic Z, Keeney E, Dowswell T, Welton NJ, Medley N, Dias S, Jones LV, Caldwell DM. Methods to induce labour: a systematic review, network meta-analysis and cost-effectiveness analysis. BJOG. 2016 Aug;123(9):1462-70. doi: 10.1111/1471-0528.13981. Epub 2016 Mar 22.
Related Links
Access external resources that provide additional context or updates about the study.
European Perinatal Health Report: Core Indicators of the Health and Care of Pregnant Women and Babies in Europe from 2015 to 2019. Euro-Peristat
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GYN2016.01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.